Cedars-Sinai Medical Center's Department of Psychiatry and Behavioral Neurosciences researchers are seeking participants in a clinical study designed to determine whether nutritional supplements that contain Omega-3 fatty acids can be an effective treatment for depression.

The National Institutes of Health (NIH)-sponsored study, held in collaboration with Massachusetts General Hospital, will recruit a total of 300 adults ages 18-80 who are experiencing significant symptoms of major depressive disorder and are in good health. The five-year study is designed to test the safety, effectiveness and tolerability of DHA and EPA against each other and a placebo. Participants will receive one of the two drugs or a placebo for eight weeks in a randomized, double-blind manner.

If you would like to participate, please call 1-888-CEDARS3 for more information.

Source